{"id":454635,"date":"2021-03-10T08:03:18","date_gmt":"2021-03-10T13:03:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454635"},"modified":"2021-03-10T08:03:18","modified_gmt":"2021-03-10T13:03:18","slug":"bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","title":{"rendered":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">VANCOUVER, British Columbia, March  10, 2021  (GLOBE NEWSWIRE) &#8212; Bright Minds Biosciences (\u201cBright Minds,\u201d \u201cBMB\u201d or the \u201cCompany\u201d) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, will be presenting at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis, as follows:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:8%;width:8%;min-width:8%\">Date:<\/td>\n<td style=\"max-width:92%;width:92%;min-width:92%\">Thursday, March 11, 2021<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>2:10PM Eastern Time<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/wsw.com\/webcast\/stifel41\/drug.cn\/2503436\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n              <u>https:\/\/wsw.com\/webcast\/stifel41\/drug.cn\/2503436<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>The presentation will be webcast live at the aforementioned time and available for one week thereafter using the link provided above.<\/p>\n<p>\n        <strong>About Bright Minds<\/strong><br \/>\n        <br \/>Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The Company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Judy DiClemente<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jJZWrIKd8Fw1jqEsrqpeRMJmBa6Kix_Kz-rdoEt3mVuQk2TVGyPX_LkOfq7FylVMrXS0h_pz0GtkQ2tb_d3ImSaYv0BiS5R2MJAAE-pChQ6wUsbB5-38xTjY2RTX6Qex\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jdiclemente@insitecony.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f2046997-3eda-43bd-9792-893d6497deeb\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) &#8212; Bright Minds Biosciences (\u201cBright Minds,\u201d \u201cBMB\u201d or the \u201cCompany\u201d) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, will be presenting at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis, as follows: Date: Thursday, March 11, 2021 Time: 2:10PM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/stifel41\/drug.cn\/2503436 The presentation will be webcast live at the aforementioned time and available for one week thereafter using the link provided above. About Bright Minds Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454635","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) &#8212; Bright Minds Biosciences (\u201cBright Minds,\u201d \u201cBMB\u201d or the \u201cCompany\u201d) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, will be presenting at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis, as follows: Date: Thursday, March 11, 2021 Time: 2:10PM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/stifel41\/drug.cn\/2503436 The presentation will be webcast live at the aforementioned time and available for one week thereafter using the link provided above. About Bright Minds Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation &hellip; Continue reading &quot;Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T13:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis\",\"datePublished\":\"2021-03-10T13:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\",\"name\":\"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\",\"datePublished\":\"2021-03-10T13:03:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","og_locale":"en_US","og_type":"article","og_title":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","og_description":"VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) &#8212; Bright Minds Biosciences (\u201cBright Minds,\u201d \u201cBMB\u201d or the \u201cCompany\u201d) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, will be presenting at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis, as follows: Date: Thursday, March 11, 2021 Time: 2:10PM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/stifel41\/drug.cn\/2503436 The presentation will be webcast live at the aforementioned time and available for one week thereafter using the link provided above. About Bright Minds Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation &hellip; Continue reading \"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T13:03:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis","datePublished":"2021-03-10T13:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","name":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference - Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=","datePublished":"2021-03-10T13:03:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM1MSM0MDU2NjM5IzIyMDQwMDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bright-minds-biosciences-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bright Minds Biosciences to Present at the Stifel GMP Healthcare Conference &#8211; Healthcare Psychedelics: Addressing the Global Mental Health Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454635"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454635\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}